Category Archives: BioUtah News
Renalytix Reports Full Year Fiscal 2022 Results
Renalytix announced its full year results for the twelve months ended 30 June 2022.
Merit Medical Reports Results for Quarter Ended September 30, 2022
Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
KidneyIntelX Medicare Update
Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage.
15th Annual 2022 Women Tech Award Recipients
The Women’s Tech Council announced eight award recipients from its twenty one finalists.
Geneial Receives $2.3M NIH Grant
Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS
SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy (DOE) to develop, design and characterize 3D-printed alumina ceramic heat exchangers for heating, ventilation, and air conditioning systems (HVAC).
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE
SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop and test an antimicrobial trauma device.
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs
CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer
Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday.
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost economics for Medicare population.
EVŌQ Bio is Fielding Partnership Inquiries for its Antimicrobial Medical Materials Additives at the MedTech Conference
Attendance at premiere medical technology convention to spur partnership, growth opportunities. SALT LAKE CITY, October 10, 2022 /PRNewswire/ – EVŌQ Bio (an EVŌQ Nano company), a nano-platform technology company, is pleased to announce their attendance at the MedTech Conference 2022 in Boston, Massachusetts October 24-26, 2022. The MedTech Conference is the premiere venue for executives […]
